CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 60.21 CNY -1.67% Market Closed
Market Cap: 6.9B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

CanSino Biologics Inc
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CanSino Biologics Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
CanSino Biologics Inc
SSE:688185
Non-Reccuring Items
-ÂĄ363m
CAGR 3-Years
N/A
CAGR 5-Years
-86%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Non-Reccuring Items
ÂĄ12.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Non-Reccuring Items
ÂĄ4.8m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Non-Reccuring Items
ÂĄ778.9k
CAGR 3-Years
-46%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Non-Reccuring Items
ÂĄ3.7m
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Non-Reccuring Items
ÂĄ146.4k
CAGR 3-Years
-31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

CanSino Biologics Inc
Glance View

Market Cap
6.9B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
100.3 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is CanSino Biologics Inc's Non-Reccuring Items?
Non-Reccuring Items
-363m CNY

Based on the financial report for Dec 31, 2023, CanSino Biologics Inc's Non-Reccuring Items amounts to -363m CNY.

What is CanSino Biologics Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
-86%

Over the last year, the Non-Reccuring Items growth was -142 816%.

Back to Top